期刊文献+

应用RNA干扰技术检测ASCT2功能 被引量:4

Measuring the function of glutamine transporter ASCT2 by RNA interference
下载PDF
导出
摘要 目的谷氨酰胺(glutamine,GLN)是肠道细胞的主要氧化燃料,必须通过载体的转运才能进入细胞内,其中载体ASCT2起重要作用,文中将应用RNA干扰(RNA interference,RNAi)技术研究肠黏膜上皮细胞株(intestinal epithelial cell,IEC)-6细胞膜GLN载体ASCT2的转运功能。方法体外培养IEC-6,RNAi慢病毒颗粒进行细胞感染,3 d后荧光显微镜下观察绿色荧光蛋白(green fluorescent protein,GFP)表达情况,5 d后采用RT-PCR检测载体ASCT2的mRNA表达,7 d后采用Western blot检测其蛋白表达,同时测定[3 H]-L-GLN摄取率。结果病毒转染细胞中均有GFP表达,载体ASCT2的mRNA表达下降60%,蛋白表达几近消失,[3H]-L-GLN摄取率下降15%。结论通过慢病毒载体介导的RNAi这一方便有效的方法,证实了ASCT2载体在整个细胞的GLN转运中起15%以上的作用。 ] Objective Glutamine,as the main oxidative fuel of enterocytes,enters the enterocyte primarily via amino acid transporters,in which AST2 plays an important role.The aim of this study was to investigate the function of the glutamine transporter ASCT2 in intestinal epithelial cell line 6(IEC-6) by RNA interference(RNAi).Methods Rat IEC-6 was incubated in vitro and transfected with the siRNA mediated by lentiviral vectors.The expression of green fluorescent protein(GFP) was detected by fluorescent microscope on the 3rd day of transfection;the mRNA expression of ASCT2 estimated by RT-PCR on the 5th day the protein expression of ASCT2 determined by Western-blot,and meanwhile the -L-glutamine uptake measured on the 7th day.Results GFP was found in all the transfected cells.The mRNA expression of ASCT2 was decreased by 60% and its protein expression was hardly observed.The total uptake of -L-glutamine was reduced by more than 15%.Conclusion RNAi mediated by lentivirus-based vectors is a convenient and effective method to test the function of ASCT2,which may contribute over 15% of total glutamine uptake.
出处 《医学研究生学报》 CAS 2011年第11期1124-1128,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(30271263)
关键词 肠黏膜上皮细胞株 [3H]-谷氨酰胺 谷氨酰胺载体 ASCT2 IEC-6 -L-glutamine glutamine transporter ASCT2
  • 相关文献

参考文献6

二级参考文献87

  • 1周济宏,李幼生,解伟光,曹亚澄,韩勇,黎介寿.肿瘤坏死因子对谷氨酰胺调控大鼠骨骼肌蛋白质合成的影响[J].医学研究生学报,2006,19(10):884-887. 被引量:7
  • 2周济宏,李幼生,黎介寿.谷氨酰胺转运载体的种类与分布及功能特点[J].医学研究生学报,2007,20(4):408-411. 被引量:10
  • 3Goeters C,Wenn A,Mertes N,et al.Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients[J].Crit Care Med,2002,30(9):2032-2037.
  • 4Dhaliwal R,Heyland DK.Nutrition and infection in the intensive care unit:what does the evidence show ?[J] Curr Opin Crit Care,2005,11(5):461-467.
  • 5Dechelotte P,Hasselmann M,Cynober L,et al.L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients:The French controlled,randomized,double-blind,multicenter study[J].Crit Care Med,2006,34(3):598-604.
  • 6Wang SJ,Chen HW,Huang MH,et al.Previous heat shock facilitates the glutamine-induced expression of heat-shock protein 72 in septic liver[J].Nutrition,2007,23(7-8):582-588.
  • 7Beale RJ,Sherry T,Lei K,et al.Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis:outcome of a randomized,controlled,double-blind trial[J].Crit Care Med,2008,36(1):131-144.
  • 8Forbes A.Parenteral nutrition[J].Curr Opin Gastroenterol,2007,23(2):183-186.
  • 9Gore DC,Wolfe RR.Glutamine supplementation fails to affect muscle protein kinetics in critically ill patients[J].JPEN,2002,26(6):342-349.
  • 10Gore DC,Wolfe RR.Metabolic response of muscle to alanine,glutamine,and valine supplementation during severe illness[J].JPEN,2003,27(5):307-314.

共引文献26

同被引文献95

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部